Evidence map›Paper›PMID 27270437›Full record

ArticleOncogene2016

Myeloid translocation genes differentially regulate colorectal cancer programs.

B Parang, A M Bradley, M K Mittal, S P Short, J J Thompson, C W Barrett, R D Naik, A J Bilotta, M K Washington, F L Revetta and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

B ParangDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
A M BradleyDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
M K MittalDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
S P ShortDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
J J ThompsonDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
C W BarrettDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
R D NaikDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
A J BilottaDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
M K WashingtonDepartment of Pathology, Microbiology, and Immunology, Nashville, TN, USA.
F L RevettaDepartment of Pathology, Microbiology, and Immunology, Nashville, TN, USA.
J J SmithDepartment of Surgery, Division of Surgical Oncology, Nashville, TN, USA.
X ChenDepartment of Biostatistics, Nashville, TN, USA.
K T WilsonDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
S W HiebertVanderbilt Ingram Cancer Center, Nashville, TN, USA.
C S WilliamsDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Vanderbilt University · USVanderbilt-Ingram Cancer CenterTennessee Oncology · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2009 to 2026
$27.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Immunomodulatory effects of arginine supplementation in colitis and colon cancerR01AT004821 · NCCIH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2008 to 2017
$4.0M
Targeted chemoprevention of gastric carcinogenesis in high risk populationsR01CA190612 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MORGAN, DOUGLAS, WILSON, KEITH T. · 2014 to 2018
$3.0M
Regulation of transcription and tumor suppression by MTG family membersR01CA178030 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2014 to 2018
$1.8M
Selenium in gastrointestinal inflammatory diseasesR01DK099204 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, CHRISTOPHER S. · 2014 to 2018
$1.8M
The role of MTGR1 in intestinal biology and inflammationK08DK080221 · NIDDK · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 2008 to 2012
$705k
The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel DiseaseF30DK096718 · NIDDK · VANDERBILT UNIVERSITY · PI PARANG, BOBAK · 2012 to 2015
$106k
Selenium and Selenoprotein P Modify Colorectal TumorigenesisF31CA167920 · NCI · VANDERBILT UNIVERSITY · PI BARRETT, CAITLYN W · 2012 to 2013
$40k
BLRD VA I01 BX001426BLRD VA I01 BX001453NCATS NIH HHS UL1 TR000445NCCIH NIH HHS R01 AT004821NCI NIH HHS F31 CA167920NCI NIH HHS P01 CA116087NCI NIH HHS P50 CA095103NCI NIH HHS R01 CA178030NCI NIH HHS R01 CA190612NCRR NIH HHS L30 RR032065NIDDK NIH HHS F30 DK096718NIDDK NIH HHS K08 DK080221NIDDK NIH HHS L30 DK076274NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK099204NIGMS NIH HHS T32 GM007347
6 · The paper itself

Abstract

Myeloid translocation genes (MTGs), originally identified as chromosomal translocations in acute myelogenous leukemia, are transcriptional corepressors that regulate hematopoietic stem cell programs. Analysis of The Cancer Genome Atlas (TCGA) database revealed that MTGs were mutated in epithelial malignancy and suggested that loss of function might promote tumorigenesis. Genetic deletion of MTGR1 and MTG16 in the mouse has revealed unexpected and unique roles within the intestinal epithelium. Mtgr1

Indexed as

AnimalsColorectal NeoplasmsFemaleHumansMaleMiceMice, Inbred C57BLNuclear ProteinsRepressor ProteinsSignal TransductionTranscription FactorsTranslocation, GeneticTumor Suppressor ProteinsCBFA2T2 myeloid-transforming gene-related proteinCBFA2T3 protein, humanCbfa2t3 protein, mouseNuclear ProteinsRepressor ProteinsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID27270437
PMCPMC5140770
OpenAlexW2467581980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.